Because of the high prevalence of genetic defects in p16/CDNK2A in non-Hodgkin B cell lymphomas, we also evaluated P16 expression in our gastric MALTs and DLBCLs. This evidence concerns the gene CDKN2A and B-cell non-Hodgkin lymphoma.